Doctors test Direct-to-Tumor immune attack for deadly brain cancer
NCT ID NCT03233152
Summary
This trial is testing a new combination of immune-boosting drugs and cells injected directly into the brain tumor during surgery for patients whose glioblastoma has returned. The goal is to see if this targeted approach can better control the cancer while reducing side effects compared to standard treatments. The study will measure how long patients live without their cancer getting worse and their overall survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universitair Ziekenhuis Brussel
Brussels, 1090, Belgium
Conditions
Explore the condition pages connected to this study.